Skip to main content
. 2020 Nov 13;20:1102. doi: 10.1186/s12885-020-07593-8

Table 3.

Multivariate analysis of prognostic factors

Characteristics P value HR 95% CI for HR
Age at diagnosis
 40–44 years Reference
 45–49 years 0.542 0.932 0.741–1.170
 50–54 years 0.878 1.017 0.821–1.260
 55–59 years 0.024 1.270 1.032–1.562
Race
 White Reference
 Black 0.001 1.317 1.127–1.540
 Other a 0.128 1.192 0.951–1.495
Marital status
 Single Reference
 Married 0.008 0.819 0.707–0.949
 Other b 0.130 0.871 0.728–1.042
Insurance (yes vs no) < 0.001 0.587 0.459–0.751
Histology
 Ductal Reference
 Lobular 0.744 1.041 0.820–1.321
 Others 0.356 1.105 0.894–1.365
Laterality
 Right Reference
 Left 0.506 1.043 0.921–1.182
Bilateral, single primary 0.177 2.21 0.894–1.365
Grade
 I Reference
 II 0.309 1.147 0.881–1.492
 III or IV < 0.001 1.960 1.491–2.577
Tumour subtype
 HR+/HER2- Reference
 HR+/HER2+ 0.002 0.631 0.474–0.839
 HR−/HER2- < 0.001 2.808 2.169–3.634
 HR−/HER2+ 0.258 0.716 0.401–1.277
Site of metastases
 Lung (yes vs no) 0.020 1.378 1.188–1.598
 Liver (yes vs no) < 0.001 2.085 1.795–2.422
 Brain (yes vs no) < 0.001 1.903 1.542–2.248
 Surgery (yes vs no) < 0.001 0.504 0.431–0.590
 HR+/HER2- * multi-metastases Reference
 HR+/HER2+ * multi-metastases 0.045 0.694 0.485–0.992
 HR−/HER2- * multi-metastases 0.717 0.941 0.675–1.310
 HR−/HER2+ * multi-metastases 0.564 0.828 0.437–1.572
Next step
 White*HR+/HER2- Reference
 Black*HR+/HER2+ 0.366 0.821 0.536–1.258
 Other a*HR+/HER2+ 0.652 0.862 0.453–1.641
 Black*HR−/HER2- 0.323 0.817 0.546–1.220
 Other a*HR−/HER2- 0.299 1.508 0.695–3.271
 Black*HR−/HER2+ 0.696 0.881 0.466–1.664
 Other a*HR−/HER2+ 0.368 0.701 0.323–1.521

Other a (American Indian/AK Native, Asian/Pacific Islander)

Other b (divorced/widowed/separated).